RISK OF THROMBOEMBOLIC DISEASES IN MEN WITH PROSTATE CANCER: RESULTS FROM PCBASE SWEDEN

被引：1
|
作者：
Van Hemelrijck, M. J. J. [1 ]
Adolfsson, J. [2 ]
Garmo, H. [1 ]
Bill-Axelson, A. [3 ]
Bratt, O. [4 ]
Ingelsson, E. [3 ]
Lambe, M. [3 ]
Stattin, P. [5 ]
Holmberg, L. [1 ]
机构：
[1] Kings Coll London, Dept Canc Epidemiol, London WC2R 2LS, England
[2] Karolinska Inst, Ctr Oncol, Dept Clintec, Stockholm, Sweden
[3] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[4] Lund Univ, Dept Urol, Lund, Sweden
[5] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60139-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] Risk of thromboembolic disease in men with prostate cancer undergoing androgen deprivation therapy
    O'Farrell, Sean
    Sandstrom, Karin
    Garmo, Hans
    Stattin, Par
    Holmberg, Lars
    Adolfsson, Jan
    Van Hemelrijck, Mieke
    BJU INTERNATIONAL, 2016, 118 (03) : 391 - 398
  • [22] Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden REPLY
    不详
    JOURNAL OF UROLOGY, 2011, 185 (03): : 840 - 840
  • [23] Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe Sweden
    Robinson, David
    Garmo, Hans
    Lindahl, Bertil
    Van Hemelrijck, Mieke
    Adolfsson, Jan
    Bratt, Ola
    Holmberg, Lars
    Stattin, Par
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 478 - 487
  • [24] Bladder cancer incidence and risk factors among men with prostate cancer: Results from capsuretm
    Boorjian, SA
    Cowan, JE
    Konety, BR
    Duchane, J
    Tewari, AK
    Carroll, PR
    Kane, CJ
    JOURNAL OF UROLOGY, 2006, 175 (04): : 286 - 286
  • [25] Androgen deprivation and thromboembolic events in men with prostate cancer
    Ehdaie, Behfar
    Atoria, Coral L.
    Gupta, Amit
    Feifer, Andrew
    Lowrance, William T.
    Morris, Michael J.
    Scardino, Peter T.
    Eastham, James A.
    Elkin, Elena B.
    CANCER, 2012, 118 (13) : 3397 - 3406
  • [26] ANDROGEN DEPRIVATION AND THROMBOEMBOLIC EVENTS IN MEN WITH PROSTATE CANCER
    Ehdaie, Behfar
    Atoria, Coral
    Gupta, Amit
    Feifer, Andrew
    Lowrance, William
    Morris, Michael
    Scardino, Peter
    Eastham, James
    Elkin, Elena
    JOURNAL OF UROLOGY, 2011, 185 (04): : E139 - E139
  • [27] Bladder cancer incidence and risk factors in men with prostate cancer: Results from cancer of the prostate strategic urologic research endeavor
    Boorjian, Stephen
    Cowan, Janet E.
    Konety, Badrinath R.
    DuChane, Janeen
    Tewari, Ashutosh
    Carroll, Peter R.
    Kane, Christopher J.
    JOURNAL OF UROLOGY, 2007, 177 (03): : 883 - 887
  • [28] Substantial Family History of Prostate Cancer in Black Men Recruited for Prostate Cancer Screening Results From the Prostate Cancer Risk Assessment Program
    Mastalski, Kathleen
    Coups, Elliot J.
    Ruth, Karen
    Raysor, Susan
    Giri, Veda N.
    CANCER, 2008, 113 (09) : 2559 - 2564
  • [29] Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden EDITORIAL COMMENT
    Froehner, Michael
    JOURNAL OF UROLOGY, 2011, 185 (03): : 839 - 839
  • [30] Sequence variants of Toll-like receptor 4 are associated with prostate cancer risk:: Results from the cancer prostate in Sweden study
    Zheng, SL
    Augustsson-Bälter, K
    Chang, BL
    Hedelin, M
    Li, LW
    Adami, HO
    Bensen, J
    Li, G
    Johnasson, JE
    Turner, AR
    Adams, TS
    Meyers, DA
    Isaacs, WB
    Xu, JF
    Grönberg, H
    CANCER RESEARCH, 2004, 64 (08) : 2918 - 2922
12345